Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions
about
Neuroimmune Control of Acute Kidney Injury and InflammationThe impact of acute stress on hormones and cytokines, and how their recovery is affected by music-evoked positive mood.Local upregulation of transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 ion channels in rectosigmoid deep infiltrating endometriosisCapsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis.Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancerProtective Effect of Adrenomedullin on Rat Leydig Cells from Lipopolysaccharide-Induced Inflammation and Apoptosis via the PI3K/Akt Signaling Pathway ADM on Rat Leydig Cells from Inflammation and Apoptosis.Galanin's implications for post-stroke improvement.Challenges to develop novel anti-inflammatory and analgesic drugs.Using the CRISPR/Cas9 system to understand neuropeptide biology and regulation.An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.Current Evidence for a Role of Neuropeptides in the Regulation of Autophagy.Interleukin-6-mediated signaling in adrenal medullary chromaffin cells.Adrenomedullin protects Leydig cells against lipopolysaccharide-induced oxidative stress and inflammatory reaction via MAPK/NF-κB signalling pathways.The Future of Atopic Dermatitis Treatment.Antinociceptive effects induced by intra-lateral habenula complex injection of the galanin receptor 1 agonist M617 in rats.Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
P2860
Q26786362-CEB50AD9-BC93-49B6-BB4B-AD47BA72054DQ27332401-A03D906E-9694-474E-9EA5-75509A74AD6EQ33657093-F16637FF-A62C-45F9-9F41-895E5C585FCFQ35146980-9EB4C2F2-26AD-4F39-BDBA-5D79C1725837Q36834005-5F92047B-4541-4E86-8552-BDAB62B87057Q36885909-4246C613-FAD7-4252-B074-F820EA8A4AB1Q37606262-C68EC2EB-B5B6-4CBC-BE7C-878A1B311270Q38941483-91FD90AA-21FA-44A2-A864-2C8BD113B59AQ39063181-41E9ACA0-43B9-46D4-9E34-7CB3A90850A3Q41139465-3053060B-1DD7-4F18-AC7B-AB7F8E850A84Q42922923-40FD8253-7A60-47F5-A837-AF6079347752Q46838416-756B5405-AFBF-4AAA-A758-0A98616601BFQ47145247-BCA53E87-1168-47BD-8EFD-8BDFC1DE75D4Q47880524-AE2C6905-E9BC-4C46-A6DF-245D019AB83AQ52147266-F239C262-3DB0-458E-9931-364B5D366C37Q58798935-4384CB70-0539-4305-A151-D68BA884AFBA
P2860
Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuropeptide receptors as pote ...... ent of inflammatory conditions
@en
Neuropeptide receptors as pote ...... nt of inflammatory conditions.
@nl
type
label
Neuropeptide receptors as pote ...... ent of inflammatory conditions
@en
Neuropeptide receptors as pote ...... nt of inflammatory conditions.
@nl
prefLabel
Neuropeptide receptors as pote ...... ent of inflammatory conditions
@en
Neuropeptide receptors as pote ...... nt of inflammatory conditions.
@nl
P2093
P2860
P356
P1476
Neuropeptide receptors as pote ...... ent of inflammatory conditions
@en
P2093
Erika Pintér
Gábor Pozsgai
János Szolcsányi
Zsuzsanna Helyes
Zsófia Hajna
P2860
P356
10.1111/BCP.12097
P407
P577
2014-01-01T00:00:00Z